Involvement of endogenous N-methyl(R)salsolinol in Parkinson's disease: Induction of apoptosis and protection by (-)deprenyl

Journal of Neural Transmission, Supplement

Volumn , Issue 58, 2000, Pages 111-121

  Naoi, M ^a   Maruyama, W ^a   Takahashi, T ^a   Akao, Y ^a   Nakagawa, Y ^a  

^a Institute of Applied Biochemistry   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HYDROXYL RADICAL; ISOQUINOLINE DERIVATIVE; NEUROTOXIN; SALSOLINOL; SELEGILINE;

APOPTOSIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DNA DAMAGE; HUMAN; LYMPHOCYTE; MITOCHONDRIAL MEMBRANE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0033678294     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6284-2_9     Document Type: Conference Paper

References (31)

1. Growth inhibition by overexpression of human DEAD box protein rck/p54 of a guinea pig cell line
2. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease
3. (-)Deprenyl increases activities of superoxide dismutase and catalase in striatum but not in hippocampus: The sex and age-related differences in the optimal dose in the rat
4. Deprenyl suppressed the oxidant stress associated with increased dopamine turnover
5. Pargyline and (-)deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys
6. Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium
7. The biochemistry of programmed cell death
8. N-Methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: In vivo microdialysis study
9. Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: In vivo and in vitro studies
10. A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in parkinsonian cerebrospinal fluid
11. An endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells
12. A dopaminergic neurotoxin, 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain
13. A neurotoxin N-methyl(R)salsolinol induces apoptotic cell death in differentiated human dopaminergic neuroblastoma SH-SY5Y cells
14. (-)-Deprenyl protects human dopaminergic neuroblastoma SH-SY5Y cells from apoptosis induced by peroxynitrite and nitric oxide
15. +) in ventral mesencephalic-striatal co-culture in rat
16. Histochemical detection of apoptosis in Parkinson's disease
17. 1-Methyl-4-phenylpyridinium kills differentiated PC12 cells with a concomitant change in protein phosphorylation
18. Enzymatic oxidation of the dopaminergic neurotoxin, 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, into 1,2(N)-dimethyl-6,7-dihydrooxyisoquino-linium ion
19. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)salsolinol, induced parkinsonism in rat
20. A novel enzyme enantioselectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol
21. +-like neurotoxin, 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion, in the substantia nigra of human brains
22. (R)Salsolinol N-methyltransferase activity increases in parkinsonian lymphocytes
23. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
24. Effect of deprenyl on the progression of disability in early Parkinson's disease
25. Deprenyl reduces the death of motoneurons caused by axotomy
26. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage
27. Detection of specific sequences among DNA fragments separated by gel electrophoresis
28. Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism
29. Modulation of gene expression rather than monoamine oxidase inhibition: (-)-Deprenyl-related compounds in controlling neurodegeneration
30. Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal; Time course and modification by (-)-deprenyl
31. + in vivo